These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6420409)

  • 1. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM; Blackburn MN
    J Biol Chem; 1984 Jan; 259(2):935-8. PubMed ID: 6420409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for essential lysines in heparin cofactor II.
    Church FC; Griffith MJ
    Biochem Biophys Res Commun; 1984 Nov; 124(3):745-51. PubMed ID: 6439196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a lysyl residue in antithrombin which is essential for heparin binding.
    Peterson CB; Noyes CM; Pecon JM; Church FC; Blackburn MN
    J Biol Chem; 1987 Jun; 262(17):8061-5. PubMed ID: 3110143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity.
    Liu CS; Chang JY
    J Biol Chem; 1987 Dec; 262(36):17356-61. PubMed ID: 3121595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structure.
    Church FC; Villanueva GB; Griffith MJ
    Arch Biochem Biophys; 1986 Apr; 246(1):175-84. PubMed ID: 3754413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refolding properties of antithrombin III. Mechanism of binding to heparin.
    Villanueva GB; Allen N
    J Biol Chem; 1983 Nov; 258(22):14048-53. PubMed ID: 6643466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III.
    Sun XJ; Chang JY
    Biochemistry; 1990 Sep; 29(38):8957-62. PubMed ID: 2271571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine residues are critical for the heparin-cofactor activity of antithrombin III.
    Jorgensen AM; Borders CL; Fish WW
    Biochem J; 1985 Oct; 231(1):59-63. PubMed ID: 4062892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.
    Carlson TH; Babcock T; Atencio AC; Levinson C; Mora HR
    J Biol Chem; 1988 Feb; 263(5):2187-94. PubMed ID: 3339006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the strength of binding of antithrombin III, protamine and poly(L-lysine) to heparin samples of different anticoagulant activities.
    Jones GR; Hashim R; Power DM
    Biochim Biophys Acta; 1986 Aug; 883(1):69-76. PubMed ID: 3730427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeling of specific lysine residues at the active site of glutamine synthetase.
    Colanduoni J; Villafranca JJ
    J Biol Chem; 1985 Dec; 260(28):15042-50. PubMed ID: 2415512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
    Nesheim M; Blackburn MN; Lawler CM; Mann KG
    J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxal 5'-phosphate, a fluorescent probe in the active site of aspartate transcarbamylase.
    Kempe TD; Stark GR
    J Biol Chem; 1975 Sep; 250(17):6861-9. PubMed ID: 239951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate promotes glycation of antithrombin III which interferes with heparin binding.
    Hall PK; Roberts RC
    Biochim Biophys Acta; 1989 Dec; 993(2-3):217-23. PubMed ID: 2597694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site.
    Villanueva GB
    J Biol Chem; 1984 Feb; 259(4):2531-6. PubMed ID: 6698980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tryptophan 49 in the heparin cofactor activity of human antithrombin III.
    Gettins P; Choay J; Crews BC; Zettlmeiss G
    J Biol Chem; 1992 Oct; 267(30):21946-53. PubMed ID: 1400504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.